The field of melanoma has been transformed by the parallel development of effective immune and targeted therapies. There is now strong evidence of cross-talk between oncogenic signaling pathways in tumors and the anti-tumor immune response, supporting the need for concurrent evaluation of immune and molecular phenotypes in patient samples. Further, there is growing evidence of the heterogeneity of immune and molecular phenotypes between, and even within, tumors. This webinar will explore oncogenic signaling pathways, resulting immune responses and the impact of heterogeneity in cancer. Examples of studies will be presented in which Digital Spatial Profiling has been used to assess immune and molecular features to make insights into the pathogenesis of melanoma.
Biochemistry
Immunology
Dna
Biomarkers
Drug Discovery
Cancer Therapeutics
Tumor
Gene Expression
Cancer Research
Cell Biology
T-Cells
Immunity
Cell Culture
Cancer
Clinical Research
North America33%
Asia33%
Europe33%
Website Visitors100%
Student50%
Research Scientist50%
Ambulatory Care33%
Biotech Company33%
Academic Institution33%